Caregen Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Yongji Chung

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	69.7%
Management average tenure	no data
Board average tenure	no data

Recent management updates

No updates

Recent updates

Caregen (KOSDAQ:214370) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Mar 18

With Caregen Co., Ltd. (KOSDAQ:214370) It Looks Like You'll Get What You Pay For

Mar 05

Do Its Financials Have Any Role To Play In Driving Caregen Co., Ltd.'s (KOSDAQ:214370) Stock Up Recently?

Jan 14

Caregen Co., Ltd. (KOSDAQ:214370) Goes Ex-Dividend Soon

Dec 25

Do Insiders Own Lots Of Shares In Caregen Co., Ltd. (KOSDAQ:214370)?

Dec 10

Is Caregen Co., Ltd. (KOSDAQ:214370) A Great Dividend Stock?

Nov 19

CEO

Yongji Chung (54 yo)

no data

Tenure

Mr. Yongji Chung, Ph D., serves as the Chief Executive Officer and Chief Technology Officer at Caregen Co., Ltd.

Caregen Management

Management criteria checks 0/4

Key information

Recent management updates

Recent updates

First quarter 2024 earnings released: EPS: ₩194 (vs ₩288 in 1Q 2023)

Caregen Co., Ltd. to Report Q1, 2024 Results on May 10, 2024

Caregen (KOSDAQ:214370) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Full year 2023 earnings released: EPS: ₩813 (vs ₩556 in FY 2022)

Investor sentiment improves as stock rises 16%

With Caregen Co., Ltd. (KOSDAQ:214370) It Looks Like You'll Get What You Pay For

Investor sentiment improves as stock rises 16%

Upcoming dividend of ₩340 per share at 2.0% yield

Third quarter 2023 earnings released: EPS: ₩199 (vs ₩128 in 3Q 2022)

Investor sentiment deteriorates as stock falls 19%

Caregen Co., Ltd. to Report Q3, 2023 Results on Nov 10, 2023

Investor sentiment deteriorates as stock falls 19%

Now 21% undervalued after recent price drop

Price target increased by 7.4% to ₩58,000

Caregen Co., Ltd. to Report Q2, 2023 Results on Aug 09, 2023

Now 24% undervalued

Upcoming dividend of ₩1,000 per share at 1.2% yield

New minor risk - Share price stability

Investor sentiment improves as stock rises 18%

First quarter 2023 earnings released: EPS: ₩1,440 (vs ₩768 in 1Q 2022)

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 19%

Full year 2022 earnings released: EPS: ₩2,778 (vs ₩2,582 in FY 2021)

Investor sentiment improves as stock rises 28%

Investor sentiment improved over the past week

Upcoming dividend of ₩1,500 per share

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: ₩640 (vs ₩669 in 3Q 2021)

Third quarter 2022 earnings released: EPS: ₩640 (vs ₩669 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of ₩800 per share

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of ₩1,300 per share

Upcoming dividend of ₩700 per share

A Look At The Fair Value Of Caregen Co., Ltd. (KOSDAQ:214370)

Here's How We Evaluate Caregen Co., Ltd.'s (KOSDAQ:214370) Dividend

Caregen (KOSDAQ:214370) Is Growing Earnings But Are They A Good Guide?

Caregen Co., Ltd. to Report Fiscal Year 2020 Results on Feb 10, 2021

Do Its Financials Have Any Role To Play In Driving Caregen Co., Ltd.'s (KOSDAQ:214370) Stock Up Recently?

New 90-day high: ₩76,300

Caregen Co., Ltd. (KOSDAQ:214370) Goes Ex-Dividend Soon

Do Insiders Own Lots Of Shares In Caregen Co., Ltd. (KOSDAQ:214370)?

New 90-day high: ₩71,400

New 90-day high: ₩66,400

Is Caregen Co., Ltd. (KOSDAQ:214370) A Great Dividend Stock?

New 90-day low: ₩60,400

CEO

Tenure